Net Cash Provided by (Used in) Financing Activities of Medtronic plc from 25 Apr 2014 to 25 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Medtronic plc quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 25 Apr 2014 to 25 Jul 2025.
  • Medtronic plc Net Cash Provided by (Used in) Financing Activities for the quarter ending 25 Jul 2025 was $1,381,000,000, a 89% decline year-over-year.
  • Medtronic plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,361,000,000, a 2% increase from 2023.
  • Medtronic plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,450,000,000, a 10% increase from 2022.
  • Medtronic plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4,960,000,000, a 7% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Medtronic plc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,381,000,000 -$650,000,000 -89% 26 Apr 2025 25 Jul 2025 10-Q 26 Aug 2025 2026 Q1
Q2 2024 $731,000,000 -$230,000,000 -46% 27 Apr 2024 26 Jul 2024 10-Q 26 Aug 2025 2026 Q1
Q2 2023 $501,000,000 +$449,000,000 +47% 29 Apr 2023 28 Jul 2023 10-Q 27 Aug 2024 2025 Q1
Q2 2022 $950,000,000 +$105,000,000 +10% 30 Apr 2022 29 Jul 2022 10-Q 31 Aug 2023 2024 Q1
Q2 2021 $1,055,000,000 -$3,014,000,000 -154% 01 May 2021 30 Jul 2021 10-Q 01 Sep 2022 2023 Q1
Q2 2020 $1,959,000,000 +$2,233,000,000 25 Apr 2020 31 Jul 2020 10-Q 02 Sep 2021 2022 Q1
Q2 2019 $274,000,000 +$1,299,000,000 +83% 27 Apr 2019 26 Jul 2019 10-Q 03 Sep 2020 2021 Q1
Q2 2018 $1,573,000,000 -$432,000,000 -38% 28 Apr 2018 27 Jul 2018 10-Q 30 Aug 2019 2020 Q1
Q2 2017 $1,141,000,000 +$19,000,000 +1.6% 29 Apr 2017 28 Jul 2017 10-Q 31 Aug 2018 2019 Q1
Q2 2016 $1,160,000,000 +$584,000,000 +33% 30 Apr 2016 29 Jul 2016 10-Q 01 Sep 2017 2018 Q1
Q2 2015 $1,744,000,000 25 Apr 2015 31 Jul 2015 10-Q 07 Sep 2016 2017 Q1

Medtronic plc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,361,000,000 +$89,000,000 +2% 27 Apr 2024 25 Apr 2025 10-K 20 Jun 2025 2025 FY
2023 $4,450,000,000 +$510,000,000 +10% 29 Apr 2023 26 Apr 2024 10-K 20 Jun 2025 2025 FY
2022 $4,960,000,000 +$376,000,000 +7% 30 Apr 2022 28 Apr 2023 10-K 20 Jun 2025 2025 FY
2021 $5,336,000,000 -$1,200,000,000 -29% 01 May 2021 29 Apr 2022 10-K 20 Jun 2024 2024 FY
2020 $4,136,000,000 +$62,000,000 +1.5% 25 Apr 2020 30 Apr 2021 10-K 22 Jun 2023 2023 FY
2019 $4,198,000,000 +$1,233,000,000 +23% 27 Apr 2019 24 Apr 2020 10-K 23 Jun 2022 2022 FY
2018 $5,431,000,000 +$6,523,000,000 +55% 28 Apr 2018 26 Apr 2019 10-K 25 Jun 2021 2021 FY
2017 $11,954,000,000 -$8,671,000,000 -264% 29 Apr 2017 27 Apr 2018 10-K 19 Jun 2020 2020 FY
2016 $3,283,000,000 +$6,260,000,000 +66% 30 Apr 2016 28 Apr 2017 10-K 21 Jun 2019 2019 FY
2015 $9,543,000,000 -$25,492,000,000 -160% 25 Apr 2015 29 Apr 2016 10-K 22 Jun 2018 2018 FY
2014 $15,949,000,000 +$16,867,000,000 26 Apr 2014 24 Apr 2015 10-K 27 Jun 2017 2017 FY
2013 $918,000,000 27 Apr 2013 25 Apr 2014 10-K 28 Jun 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.